Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer.
In Vivo
; 36(4): 1820-1828, 2022.
Article
in En
| MEDLINE
| ID: mdl-35738585
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colonic Neoplasms
/
Neoplasm Recurrence, Local
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
In Vivo
Journal subject:
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: